State Street SPDR S&P Biotech ETF

XBIAMEX · USD
152.21USD+3.81 (+2.57%)

State Street SPDR S&P Biotech ETF (XBI) Covered Calls

State Street SPDR S&P Biotech ETF trades in the Exchange Traded Fund industry with an IV Rank of 99.21%, high versus the past year. XBI's highest covered call setup is the $167.00 strike expiring Nov 6, 2026, sorted by theoretical annualized return. It's 12.53% out of the money with 1 days to expiration, a 12.54% return until expiration, and a 4,577.26% theoretical annualized return. Across the setups shown, annualized returns run from 998.58% to 4,577.26% at strikes between $152.00 and $167.00, with 1 to 1 days to expiration, as of Nov 5, 2026.

Read more

Running XBI covered calls helps you generate income from State Street SPDR S&P Biotech ETF shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best XBI covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If XBI stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling XBI covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given XBI covered call is worth writing.

The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

2026-11-061167.0012.530.010.501861.0012.544577.26-0.01+0.06330.49
2026-11-061159.007.140.020.251062.007.162612.06-0.01+0.053990.23
2026-11-061158.006.470.080.42968.006.522380.86-0.05+0.081010.34
2026-11-061157.005.800.080.24868.005.852134.91-0.05+0.073960.16
2026-11-061156.005.120.130.35773.005.211901.25-0.09+0.091600.22
2026-11-061155.004.450.200.59680.004.581672.51-0.13+0.141920.39
2026-11-061154.003.770.310.55591.003.981453.61-0.21+0.162520.24
2026-11-061153.003.100.301.35490.003.301205.19-0.20+0.24551.05
2026-11-061152.502.760.512.75461.003.111133.86-0.34+0.32492.24
2026-11-061152.002.430.462.29406.002.74998.58-0.31+0.31471.83

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryExchange Traded Fund
  • SectorFinancial
  • IV Rank99.21% High
  • Market cap (M$)—
  • 52 weeks high-12.65%
  • 52 weeks low39.60%
  • Analyst recommendation—
  • Target price—
  • Dividend—
  • Payout ratio—
  • Earnings date—
  • P/E—
  • Future P/E—
  • EPS (ttm)—
  • EPS growth next 5 years—

As of Nov 5, 2026